Answers are grounded in this paper and cite their sources.
An in depth knowledge is essential about the pathology of immune thrombocytopenias before we start managing these autoimmune disorders. It’s important to differentiate whether the patient has primary or secondary immune thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Piyush Vyas (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: